Anixa Biosciences Provides Update on CAR-T Program
- Friday, December 13, 2019, 7:00
- Finance
- Add a comment
SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, today announced an update regarding the chimeric antigen receptor T-cell (CAR-T) technology it is…
About the Author
adminasapcorp has written 42188 stories on this site.